Sign in
CompletedNo phase

Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)

Key facts

Who runs it
University Hospital of North Norway
Where
Norway2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
332 people enrolled
Started
3 Nov 2017
Ended
20 Sept 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Calanus oil
  • Medical Paraffin
Record updated
22 June 2025

Who can take part

Age
6 years to 16 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • ADHD according to DSM-IV criteria

Who cannot take part

  • ADHD medication
  • infantil autism, psychosis, bipolar disorders and serious somatic disease
  • IQ below 70
  • any abnormal or pathological blood test during trial

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to determine if marine monounsaturated and polyunsaturated fatty acids can benefit children aged 6-16 years with ADHD and related symptoms. It is a randomized, double-blind, placebo-controlled study involving approximately 330 children from Norway. The study will assess ADHD symptoms reported by caregivers, teachers, and the child at baseline, after 6 months of treatment, and 6 months post-treatment. Secondary outcomes will include reading and writing difficulties, cognitive functions, and physical health.

The 2 groups in the trial

  • Calanus oilExisting treatment, for comparison

    Children receiving omega-3 in form om calanus oil in capsule form

  • PlaceboPlacebo, for comparison

    Children receiving medical paraffin in capsule form (2 ml volume per day)

    Treatment: Medical Paraffin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ADHD and Nutrition: The Influence of Omega-3 on ADHD Related Symptoms
Publications
Record updated
22 June 2025